MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference26 articles.
1. Challenges and opportunities in studying the epidemiology of ovarian Cancer subtypes;Doherty;Curr. Epidemiol. Rep.,2017
2. Ovarian collision tumors: imaging findings, pathological characteristics, diagnosis, and differential diagnosis;Peng;Abdom. Radiol. (NY),2017
3. Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - an updated review;Muinao;Exp. Cell. Res.,2018
4. Advances in ovarian cancer therapy;Cortez;Cancer Chemother. Pharmacol.,2017
5. miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance;Samuel;Expert Rev. Anticancer Ther.,2016
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in unlocking the complexity of polycystic ovary syndrome: Insights into competing endogenous RNA networks and their implications;Non-coding RNA Research;2024-01
2. Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer;Current Oncology;2023-12-29
3. Expression Analysis and Bioinformatics-Based Identification of miR-4534, miR-551a and miR-1294 in Breast Cancer;INT J HUM GENET;2023
4. Coding and noncoding RNA profile of human heterotopic ossifications - Risk factors and biomarkers;Bone;2023-11
5. LncASAP1-IT1 promotes hepatocellular carcinoma progression through the regulation of the miR-1294/TGFBR1 pathway in vitro and in vivo;Journal of Gastrointestinal Oncology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3